First human test of ZL-1503 begins to uncover how the body handles it
Knowledge-focused
Not yet recruiting
This early-stage trial is testing a new drug called ZL-1503 in healthy volunteers. The goal is to understand how the drug moves through the body, how safe it is, and how well people tolerate it after a single injection under the skin or into a vein. The study involves 36 healthy …
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC